MIXTURES AND COMPOSITIONS COMPRISING PAENIBACILLUS STRAINS OR FUSARICIDINS AND CHEMICAL PESTICIDESThe present invention relates to novel mixtures comprising, as active components, at least one isolated bacterial strain, which is a member of the genus Paenibacillus, or a cell-free extract thereof or at least one metabolite thereof, and at least one chemical pesticide. The present invention also relates to compositions comprising at least one of such bacterial strains, whole culture broth or a cell-free extract or a fraction thereof or at least one metabolite thereof, and at least one chemical pesticide. The present invention also relates to a method of controlling or suppressing plant pathogens or preventing plant pathogen infections by applying such composition. The present invention also relates to mixtures of fusaricidins which are pesticidal metabolites produced by the abovementioned strains, and chemical pesticides.A mixture, comprising as active components 1) at least one Paenibacillus strain, a culture medium, a cell-free extract or at least one metabolite thereof; wherein the at least one Paenibacillus strain is selected from the group consisting of:a) Paenibacillus strain Lu16774 deposited with DSMZ under Accession No. DSM 26969;b) Paenibacillus strain Lu17007 deposited with DSMZ under Accession No. DSM 26970;c) Paenibacillus strain Lu17015 deposited with DSMZ under Accession No. DSM 26971; andd) a bacterial strain which comprises a DNA sequence exhibiting d1) at least 99.6% nucleotide sequence identity to the DNA sequences SEQ ID NO:4 or SEQ ID NO:9; ord2) at least 99.8% nucleotide sequence identity to the DNA sequence SEQ ID NO:14; ord3) at least 99.9% nucleotide sequence identity to the DNA sequences SEQ ID NO:5 or SEQ ID NO:10; ord4) at least 99.2% nucleotide sequence identity to the DNA sequence SEQ ID NO:15; ord5) at least 99.2% nucleotide sequence identity to the DNA sequences SEQ ID NO:6 or SEQ ID NO: 11; ord6) at least 99.8% nucleotide sequence identity to the DNA sequence SEQ ID NO:16; ord7) at least 99.8% nucleotide sequence identity to the DNA sequences SEQ ID NO:7 or SEQ ID NO: 12; ord8) at least 99.3% nucleotide sequence identity to the DNA sequence SEQ ID NO:17; ord9) 100.0% nucleotide sequence identity to the DNA sequences SEQ ID NO:8 or SEQ ID NO: 13; ord10) at least 99.9% nucleotide sequence identity to the DNA sequence SEQ ID NO: and2) at least one pesticide II selected from selected from the groups A) to N): A) Respiration inhibitors Inhibitors of complex III at Qo site: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxy-methyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone, methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate, 1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(2,4-dichloro-phenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[1-[3-(tri-fluoromethyl)phenyl]-ethylideneamino]oxymethyl]phenyl]tetrazol-5-one, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, pyriminostrobin, bifujunzhi, 2-(ortho-((2,5-dimethylphenyl-oxymethylen)phenyl)-3-methoxy-acrylic acid methylester;inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(6S,7R,8R)?S-benzyl-3-[(3-hydroxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [2-[[(7R,8R,9S-7-benzyl-9-methyl-8-(2-methylpropanoyloxy)-2,6-dioxo-1,5-dioxonan-3-yl]carbamoyl]-4-methoxy-3-pyridyl]oxymethyl 2-methylpropanoate, [(6S,7R,8R)-8-benzyl-3-[[4-methoxy-3-(propanoyloxymethoxy)pyridine-2-carbonyl]amino]-6-methyl-49-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; inhibitors of complex II: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethyl-indan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, methyl (E)-2-[2-[(5-cyano-2-methyl-phenoxy)methyl]phenyl]-3-methoxy-prop-2-enoate;other respiration inhibitors: diflumetorim; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam, fer...
파에니바실러스 균주 또는 푸자리시딘 및 화학적 살충제를 포함하는 혼합물 및 조성물본 발명은 파에니바실러스(Paenibacillus) 속의 구성원인 하나 이상의 단리된 박테리아 균주, 또는 그의 무세포 추출물 또는 그의 하나 이상의 대사산물, 및 하나 이상의 화학 살충제를 활성 성분으로서 포함하는 신규 혼합물에 관한 것이다. 본 발명은 또한 적어도 하나의 이러한 박테리아 균주, 전체 배양 브로쓰 또는 무세포 추출물 또는 이의 분획 또는 이의 적어도 하나의 대사산물, 및 적어도 하나의 화학 살충제를 포함하는 조성물에 관한 것이다. 본 발명은 또한 이러한 조성물을 적용하여 식물 병원체를 방제 또는 억제하거나 식물 병원체 감염을 예방하는 방법에 관한 것이다. 본 발명은 또한 상기 언급된 균주에 의해 생성된 살충 대사산물인 푸사리시딘과 화학 살충제의 혼합물에 관한 것이다.활성 성분으로서 1) 적어도 하나의 파에니바실러스 균주, 배양 배지, 무세포 추출물 또는 이들의 적어도 하나의 대사물; 여기서 적어도 하나의 파에니바실러스 균주는 a) 수탁 번호 DSM 26969 하에 DSMZ에 기탁된 파에니바실러스 균주 Lu16774;b) 수탁 번호 DSM 26970 하에 DSMZ에 기탁된 파에니바실러스 균주 Lu17007;c) 파에니바실러스 균주 Lu170 수탁 번호 DSM 26971로 DSMZ에 기탁되며; 및d) d1) 서열번호 4 또는 서열번호 9의 DNA 서열과 99.6% 이상의 뉴클레오티드 서열 동일성을 나타내는 DNA 서열을 포함하는 박테리아 균주; ord2) DNA 서열 SEQ ID NO:14에 대해 적어도 99.8% 뉴클레오티드 서열 동일성; ord3) DNA 서열 SEQ ID NO:5 또는 SEQ ID NO:10에 대해 적어도 99.9% 뉴클레오티드 서열 동일성; ord4) 서열번호 15의 DNA 서열과 99.2% 이상의 뉴클레오티드 서열 동일성; ord5) 서열번호 6 또는 서열번호 11의 DNA 서열과 99.2% 이상의 뉴클레오티드 서열 동일성; ord6) DNA 서열 SEQ ID NO:16에 대해 적어도 99.8% 뉴클레오티드 서열 동일성; ord7) SEQ ID NO:7 또는 SEQ ID NO:12의 DNA 서열에 대해 적어도 99.8% 뉴클레오티드 서열 동일성; ord8) DNA 서열 SEQ ID NO:17에 대해 적어도 99.3% 뉴클레오티드 서열 동일성; ord9) SEQ ID NO:8 또는 SEQ ID NO:13의 DNA 서열에 대한 100.0% 뉴클레오티드 서열 동일성; ord10) SEQ ID NO:의 DNA 서열과 99.9% 이상의 뉴클레오티드 서열 동일성 및2) 그룹 A) 내지 N)에서 선택되는 하나 이상의 살충제 II: A) 호흡 억제제 Qo 부위에서 복합체 III의 억제제: 아족시스트로빈, 쿠메톡시스트로빈, 쿠목시스트로빈, 디목시스트로빈, 에네스트로부린, 페나민스트로빈, 페녹시스트로빈/플루페녹시스트로빈, 플루옥사스트로빈, 크레속심-메틸, 만데스트로빈, 메토미노스트로빈, 오리사스트로빈, 피폭시스트로빈, 피라클로스트로빈, 페닐, 3,피라메토스트로빈, 피라옥시스트로빈, 피라옥시스트로빈 )-1-메틸-알릴리덴아미노옥시-메틸)-페닐)-2-메톡시이미노-N-메틸-아세트아미드, 피리벤카브, 트리클로피리카브/클로로딘카브, ​​파목사돈, 페나미돈, 메틸-N-[2-[(1,4-디메틸-5) -페닐-피라졸-3-일)옥실메틸]페닐]-N-메톡시-카바메이트, 1-[3-클로로-2-[[1-(4-클로로페닐)-1H-피라졸-3-일]옥시메틸]페닐 ]-4-메틸-테트라졸-5-온, 1-[3-브로모-2-[[1-(4-클로로페닐)피라졸-3-일]옥시메틸]페닐]-4-메틸-테트라졸-5-온 , 1-[2-[[1-(4-클로로페닐)피라졸-3-일]옥심 에틸]-3-메틸-페닐]-4-메틸-테트라졸-5-온, 1-[2-[[1-(4-클로로페닐)피라졸-3-일]옥시메틸]-3-플루오로-페닐]- 4-메틸-테트라졸-5-온, 1-[2-[[1-(2,4-디클로로-페닐)피라졸-3-일]옥시메틸]-3-플루오로-페닐]-4-메틸-테트라졸- 5-온, 1-[2-[[4-(4-클로로페닐)티아졸-2-일]옥시메틸]-3-메틸-페닐]-4-메틸-테트라졸-5-온, 1-[3-클로로 -2-[[4-(p-톨릴)티아졸-2-일]옥시메틸]페닐]-4-메틸-테트라졸-5-온, 1-[3-시클로프로필-2-[[2-메틸-4- (1-메틸피라졸-3-일)페녹시]메틸]페닐]-4-메틸-테트라졸-5-온, 1-[3-(디플루오로메톡시)-2-[[2-메틸-4-(1-메틸피라졸- 3-일)페녹시]메틸]페닐]-4-메틸-테트라졸-5-온, 1-메틸-4-[3-메틸-2-[[2-메틸-4-(1-메틸피라졸-3-일) )페녹시]메틸]페닐]테트라졸-5-온, 1-메틸-4-[3-메틸-2-[[1-[3-(트리플루오로메틸)페닐]-에틸리덴아미노]옥시메틸]페닐]테트라졸-5 -온, (Z,2E)-5-[1-(2,4-디클로로페닐)피라졸-3-일]-옥시-2-메톡시이미노-N,3-디메틸-펜트-3-엔아미드, (Z,2E )-5-[1-(4-클로로페닐)피라졸-3-일]옥시-2-메톡시이미노-N,3-디메틸-펜트-3-에나미 드, 피리미노스트로빈, 비푸준지, 2-(오르토-((2,5-디메틸페닐-옥시메틸렌)페닐)-3-메톡시-아크릴산 메틸에스테르; Qi 부위에서 복합체 III의 억제제: 시아조파미드, 아미설브롬, [(6S,7R, 8R)?S-벤질-3-[(3-히드록시-4-메톡시-피리딘-2-카르보닐)아미노]-6-메틸-4,9-디옥소-1,5-디옥소난-7-일]2- 메틸프로파노에이트, [2-[[(7R,8R,9S-7-벤질-9-메틸-8-(2-메틸프로파노일옥시)-2,6-디옥소-1,5-디옥소난-3-일]카르바모일]-4 -메톡시-3-피리딜]옥시메틸 2-메틸프로파노에이트, [(6S,7R,8R)-8-벤질-3-[[4-메톡시-3-(프로파노일옥시메톡시)피리딘-2-카보닐]아미노]-6-메틸 -49-디옥소-1,5-디옥소난-7-일]2-메틸프로파노에이트; 복합체 II의 억제제: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, tecloftifluzamade, -메틸-N-(1,1,3-트리메틸인단-4-일)피라졸-4-카르복사미드, 3-(트리플루오로메틸)-1-메틸-N-(1,1,3-트리메틸-인단-4-일 )피라졸-4-카르복사미드, 1,3-디메틸-N-(1,1,3-트리메틸인단-4-일)피라졸-4-카르복사미드, 3-(트리플루오로메틸)-1,5-디메틸-N-(1 ,1,3-트리메틸인단-4-일)피라졸-4-카르복사미드, 1,3,5-트리메틸-N-(1,1,3-트리메틸인단-4-일)피라졸-4-카르복사미드, 3-(디플루오로메틸) )-1,5-디메틸-N-(1,1,3-트리메틸인단-4-일)피라졸-4-카르복사미드, 3-(디플루오로메틸)-N-(7-플루오로-1,1,3-트리메틸- 인단-4-일)-1-메틸-피라졸-4-카르복사미드, 메틸 (E)-2-[2-[(5-시아노-2-메틸-페녹시)메틸]페닐]-3-메톡시-프로프- 2-에노에이트, 기타 호흡 억제제: 디플루메토림; 니트로페닐 유도체: 비나파크릴, 디노부톤, 디노캡, 플루아지남, 페르...를 포함하는 혼합물.